GLP-1 Supplements: Every Ingredient Graded by the Evidence

A large market has grown around supplements marketed as "natural GLP-1 boosters" — projected to grow from roughly $2.24 billion in 2026 to $5.53 billion by 2034. The premise is that certain compounds stimulate your body's own GLP-1 secretion. Some genuinely do, in a laboratory. This review grades every commonly marketed ingredient by the strength of the human evidence behind it, and explains why even the best of them is not doing what the drugs do.

The Pharmacological Problem

Before grading individual ingredients, one point governs the entire category. Native GLP-1 secreted by your intestinal L-cells has a half-life measured in minutes — it is degraded almost immediately by the enzyme DPP-4. That is precisely the problem semaglutide and tirzepatide were engineered to solve: they are modified to resist that degradation, which is why they are dosed weekly and sustain receptor activation continuously.

A supplement that nudges endogenous secretion upward is producing a small, transient rise in a hormone that disappears within minutes. A GLP-1 receptor agonist produces sustained pharmacological receptor activation for a week. These are not the same intervention at different doses; they are different in kind. See how GLP-1 medications work for the underlying pharmacology.

How These Grades Work

• Grade B — Human randomized trials showing modest but real metabolic or weight effects
• Grade C — Human data limited, inconsistent, or on surrogate markers only
• Grade D — Mechanistic support from cell or animal studies; human evidence thin or absent
• Grade F — Evidence contradicts the marketing claim, or key evidence has been withdrawn

No ingredient earns an A. That grade would require human trials demonstrating weight loss approaching pharmacotherapy, and none exists.

Grade B — The Best of a Modest Field

Berberine

The flagship of the category, widely marketed as "nature's Ozempic." Clinical studies show berberine produces A1c reductions of roughly 0.5–0.7%, compared with substantially larger effects from GLP-1 agonists. Ohio State reports some studies showing modest weight loss between 5% and 7% of body weight.

The counterweight is significant: the American Academy of Family Physicians characterizes berberine as a weight-loss fad that lacks rigorous evidence and has potential harms. UCLA Health notes early studies suggest benefits may extend beyond weight, while pharmacy and clinical reviewers are consistent that it is not an Ozempic replacement and is not risk-free. Our full berberine review covers the drug interactions in detail.

Resistant starch

One of the better-supported entries, and rarely the one being sold. Zhou et al. (2008, over 600 citations) demonstrated that dietary resistant starch increased GLP-1 and PYY secretion. More recently, Li et al. (2024, over 270 citations) found that resistant starch at 40 g/day for 8 weeks helped achieve weight loss.

An important honesty check comes from Keenan et al. (2015): only one of several studies reported an increase in serum GLP-1 associated with added resistant starch, implying other mechanisms are involved. The weight effect looks more reliable than the GLP-1 mechanism claimed for it.

Chromium picolinate

A systematic review and meta-analysis in patients with diabetes found chromium supplementation improved glycemic control. Randomized, double-blind, placebo-controlled work has examined chromium picolinate over six months in people at risk of type 2 diabetes. The evidence sits on glycemic markers rather than weight, and it is a glucose-metabolism story rather than a GLP-1 one.

Inulin and soluble fiber blends

Clinical evidence shows inulin-type fructans and soluble fibres reduce fasting glucose and HbA1c. Notably, a Nutrients analysis found that a supplement combining glucomannan, inulin, psyllium and apple fiber was most effective at reducing BMI, body weight, and CRP — suggesting fiber blends outperform single ingredients.

Grade C — Real Signals, Thin Human Data

Capsaicin

Among the better mechanistic cases with some human support. Zheng et al. (2017) describe capsaicin modulating gastrointestinal function and gut microbiome including stimulation of GLP-1 secretion. Van Avesaat et al. (2016) found increased GLP-1 concentrations after a capsaicin-containing lunch versus placebo. Panchal et al. (2018) showed acute capsaicin increased GLP-1 and insulin secretion in mice in a TRPV1-dependent manner. Real, but small and postprandial.

Glucomannan (konjac)

Preclinical studies show konjac glucomannan improves insulin signaling, reduces adipose tissue inflammation, and inhibits diet-induced obesity in animal models. The human-relevant finding is simpler and more plausible: as a viscous dietary fiber it improves subjective satiety and reduces appetite. That is a bulk-and-viscosity effect, not a hormonal one.

Fenugreek

Ethanol extracts from fenugreek seeds enhanced GLP-1 signaling, and seeds have been found to reduce glucose and glycated hemoglobin. A review identified 98 articles reporting antidiabetic effects across in vitro, in vivo, and clinical work. Note that an extract used in a laboratory is not the same preparation as a capsule on a shelf.

Alpha-lipoic acid and L-carnitine

Alpha-lipoic acid showed small weight loss effects in a meta-analysis of randomized controlled trials. L-carnitine reduced BMI and body weight when co-administered with a synbiotic, but most studies show modest or inconsistent results for weight loss in the general population. Neither has a meaningful GLP-1 story.

Grade D — Laboratory Findings Sold as Human Results

Akkermansia muciniphila

Heavily marketed, including in industry analyses positioning probiotic Akkermansia formulas as affordable Ozempic alternatives. The actual evidence: Cani et al. (2021) confirmed Akkermansia improved diet-induced obesity and insulin resistance in mice. Arukha et al. (2025) demonstrated that extracts modestly increase insulin secretion from INS-1 beta cells — a cultured cell line.

Mice and cell lines are legitimate science and a reasonable basis for further research. They are not a basis for claiming a consumer weight-loss effect.

Butyrate and postbiotics

Yadav et al. (2013, over 880 citations) observed that butyrate increased GLP-1 secretion from intestinal L-cells, and in vitro work shows propionate and butyrate increase GLP-1 and PYY secretion via GPR43. This is genuinely interesting mechanism — and it is in vitro. The leap from L-cells in a dish to a person losing weight is exactly where the marketing gets ahead of the science.

Gymnema sylvestre

Experimental studies show bioactive compounds enhance glucose-stimulated insulin secretion while preserving beta-cell viability. Animal studies suggest Gymnema preparations inhibit intestinal glucose uptake or increase insulin. The literature is dominated by experimental and animal work.

Cinnamon

Cinnamon extract improved beta-cell responsiveness in study conditions, and cinnamon aqueous extract decreased serum glucose by around 52% relative to controls — in an animal model. Cinnamon also appears in reviews of herbal constituents alongside berberine, tea, curcumin, and resveratrol as compounds with metabolic activity.

Curcumin, ginseng, yerba mate, bitter melon, green tea/EGCG

These recur constantly in listicles — GoodRx names psyllium, berberine, yerba mate, curcumin, ginseng, and wild bitter gourd as supplements that increase GLP-1 — but the underlying GLP-1-specific human evidence is thin for each. Green tea EGCG is described as increasing GLP-1 levels, largely in mechanistic contexts. Being frequently listed is not the same as being well studied.

Grade F — Where the Evidence Runs the Other Way

Psyllium — the contradiction at the center of the category

Psyllium is the single most-cited "GLP-1 booster," frequently listed first. The trial evidence complicates that badly.

Karhunen et al. (2010) — a study titled, plainly, "A Psyllium Fiber-Enriched Meal Strongly Attenuates Postprandial Gastrointestinal Peptide Release" — found that 23 g of psyllium attenuated the GLP-1 response, and that postprandial GLP-1 concentration was significantly suppressed after a fiber- and protein-rich meal.

Other sources describe psyllium as contributing to a modest enhancement of endogenous GLP-1 secretion, and Gibb et al. (2015) found psyllium improves glycemic control with significantly decreased peak postprandial glucose in most studies examined. So psyllium looks genuinely useful for glucose and for constipation — but the specific claim that it boosts GLP-1 is contradicted by one of the most direct trials on the question.

That matters because psyllium is the ingredient most often used to justify the category's central premise.

What Actually Raises Endogenous GLP-1

Ohio State lists the practical levers for naturally stimulating GLP-1: protein, healthy fats, fiber, probiotics and fermented foods, and dark chocolate. Telehealth and clinical sources converge on a similar list — protein, fiber, water, sleep, and stress reduction — with supplements appearing as a secondary consideration.

Protein is the most reliable GLP-1 secretagogue most people are not using deliberately, and it costs nothing to prioritize. Our guide to eating for satiety covers the practical construction.

The Regulatory Reality

Under the FTC Act there is no pre-market approval requirement for health claims in supplement advertising. Products reach shelves first; enforcement, if it comes, comes later.

Enforcement is active. The FTC maintains Penalty Offenses Concerning Weight Loss and Health Products Compliance Guidance, and has sent refund checks totaling more than $437,000 to consumers who bought bogus weight-loss products. Bloomberg Law reports consumers suing supplement producers over deceptive marketing of products claimed to promote the body's GLP-1 production — including a class action against a celebrity-founded brand's GLP-1 daily supplement. Advertising-law commentary aimed at this industry is blunt: avoid unsubstantiated weight loss claims at all costs.

Safety Is Not Automatic

"Natural" does not mean inert. Berberine is specifically flagged as not risk-free and carries real drug-interaction potential. Viscous fibers can interfere with the absorption of other oral medications — relevant to anyone taking a daily prescription. Anything affecting blood glucose can compound the effect of diabetes medication.

Tell your prescriber and pharmacist what you take. Supplements are frequently omitted from medication lists precisely because people do not think of them as drugs.

The Bottom Line

The honest summary of this entire category: a handful of ingredients have real mechanistic activity and a few produce modest metabolic improvements in humans. Berberine, resistant starch, chromium and fiber blends are the most defensible. Akkermansia, butyrate, gymnema and cinnamon rest largely on cells and animals. The apple cider vinegar headline was retracted, and psyllium — the most-cited booster of all — has direct trial evidence of attenuating the GLP-1 response.

None of this is a reason to dismiss fiber or protein, which are genuinely useful. It is a reason to reject the framing. These products are not weaker versions of GLP-1 medications; they act through different mechanisms at a different order of magnitude. If you want the effect the drugs produce, the supplements are not a substitute — and if you are already on a GLP-1, the supplements worth considering are entirely different ones.